PURPOSE: To examine the impact of a targeted exome approach for the molecular diagnosis of patients nationwide with a wide range of ataxia-related phenotypes. METHODS: One hundred and seventy patients with ataxia of unknown etiology referred from clinics throughout the United States and Canada were studied using a targeted exome approach. Patients ranged in age from 2 to 88 years. Analysis was focused on 441 curated genes associated with ataxia and ataxia-like conditions. RESULTS: Pathogenic and suspected diagnostic variants were identified in 88 of the 170 patients, providing a positive molecular diagnostic rate of 52%. Forty-six different genes were implicated, with the six most commonly mutated genes being SPG7, SYNE1, ADCK3, CACNA1A, ATP1A3, and SPTBN2, which accounted for >40% of the positive cases. In many cases a diagnosis was provided for conditions that were not suspected and resulted in the broadening of the clinical spectrum of several conditions. CONCLUSION: Exome sequencing with targeted analysis provides a high-yield approach for the genetic diagnosis of ataxia-related conditions. This is the largest targeted exome study performed to date in patients with ataxia and ataxia-like conditions and represents patients with a wide range of ataxia phenotypes typically encountered in neurology and genetics clinics.
PURPOSE: To examine the impact of a targeted exome approach for the molecular diagnosis of patients nationwide with a wide range of ataxia-related phenotypes. METHODS: One hundred and seventy patients with ataxia of unknown etiology referred from clinics throughout the United States and Canada were studied using a targeted exome approach. Patients ranged in age from 2 to 88 years. Analysis was focused on 441 curated genes associated with ataxia and ataxia-like conditions. RESULTS: Pathogenic and suspected diagnostic variants were identified in 88 of the 170 patients, providing a positive molecular diagnostic rate of 52%. Forty-six different genes were implicated, with the six most commonly mutated genes being SPG7, SYNE1, ADCK3, CACNA1A, ATP1A3, and SPTBN2, which accounted for >40% of the positive cases. In many cases a diagnosis was provided for conditions that were not suspected and resulted in the broadening of the clinical spectrum of several conditions. CONCLUSION: Exome sequencing with targeted analysis provides a high-yield approach for the genetic diagnosis of ataxia-related conditions. This is the largest targeted exome study performed to date in patients with ataxia and ataxia-like conditions and represents patients with a wide range of ataxia phenotypes typically encountered in neurology and genetics clinics.
Authors: Michael J Bamshad; Sarah B Ng; Abigail W Bigham; Holly K Tabor; Mary J Emond; Deborah A Nickerson; Jay Shendure Journal: Nat Rev Genet Date: 2011-09-27 Impact factor: 53.242
Authors: Roula Ghaoui; Sandra T Cooper; Monkol Lek; Kristi Jones; Alastair Corbett; Stephen W Reddel; Merrilee Needham; Christina Liang; Leigh B Waddell; Garth Nicholson; Gina O'Grady; Simranpreet Kaur; Royston Ong; Mark Davis; Carolyn M Sue; Nigel G Laing; Kathryn N North; Daniel G MacArthur; Nigel F Clarke Journal: JAMA Neurol Date: 2015-12 Impact factor: 18.302
Authors: Brent L Fogel; Hane Lee; Joshua L Deignan; Samuel P Strom; Sibel Kantarci; Xizhe Wang; Fabiola Quintero-Rivera; Eric Vilain; Wayne W Grody; Susan Perlman; Daniel H Geschwind; Stanley F Nelson Journal: JAMA Neurol Date: 2014-10 Impact factor: 18.302
Authors: M Anheim; P Chamouard; G Rudolf; B Ellero; L Vercueil; B Goichot; C Marescaux; C Tranchant Journal: Clin Genet Date: 2010-09 Impact factor: 4.438
Authors: Ada Hamosh; Alan F Scott; Joanna S Amberger; Carol A Bocchini; Victor A McKusick Journal: Nucleic Acids Res Date: 2005-01-01 Impact factor: 16.971
Authors: Sarah L Sawyer; Jeremy Schwartzentruber; Chandree L Beaulieu; David Dyment; Amanda Smith; Jodi Warman Chardon; Grace Yoon; Guy A Rouleau; Oksana Suchowersky; Victoria Siu; Lisa Murphy; Robert A Hegele; Christian R Marshall; Dennis E Bulman; Jacek Majewski; Mark Tarnopolsky; Kym M Boycott Journal: Hum Mutat Date: 2014-01 Impact factor: 4.878
Authors: Liedewei Van de Vondel; Jonathan De Winter; Danique Beijer; Giulia Coarelli; Melanie Wayand; Robin Palvadeau; Martje G Pauly; Katrin Klein; Maren Rautenberg; Léna Guillot-Noël; Tine Deconinck; Atay Vural; Sibel Ertan; Okan Dogu; Hilmi Uysal; Vesna Brankovic; Rebecca Herzog; Alexis Brice; Alexandra Durr; Stephan Klebe; Friedrich Stock; Almut Turid Bischoff; Tim W Rattay; María-Jesús Sobrido; Giovanna De Michele; Peter De Jonghe; Thomas Klopstock; Katja Lohmann; Ginevra Zanni; Filippo M Santorelli; Vincent Timmerman; Tobias B Haack; Stephan Züchner; Rebecca Schüle; Giovanni Stevanin; Matthis Synofzik; A Nazli Basak; Jonathan Baets Journal: Mov Disord Date: 2022-02-12 Impact factor: 9.698
Authors: Kathie J Ngo; Jessica E Rexach; Hane Lee; Lauren E Petty; Susan Perlman; Juliana M Valera; Joshua L Deignan; Yuanming Mao; Mamdouh Aker; Jennifer E Posey; Shalini N Jhangiani; Zeynep H Coban-Akdemir; Eric Boerwinkle; Donna Muzny; Alexandra B Nelson; Sharon Hassin-Baer; Gemma Poke; Katherine Neas; Michael D Geschwind; Wayne W Grody; Richard Gibbs; Daniel H Geschwind; James R Lupski; Jennifer E Below; Stanley F Nelson; Brent L Fogel Journal: Hum Mutat Date: 2019-11-25 Impact factor: 4.700
Authors: Ida Stenshorne; Magnhild Rasmussen; Panagiotis Salvanos; Chantal M E Tallaksen; Laurence A Bindoff; Jeanette Koht Journal: Cerebellum Ataxias Date: 2019-02-08